LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX) today announced that it has expanded the company’s research and development team with the appointment of Sheila DeWitt, Ph.D. to the newly-created role of vice president of discovery, and the appointment of Tom Megerian, M.D., Ph.D. to the position of executive director, clinical research. In addition, Sharon Shacham, Ph.D. and Simon Jones, Ph.D. have transitioned into roles of increased responsibility within the R&D team.
